Front > MARKET

MARKET

Teva Photo: Reuters Teva hit as US hospitals form generic drug rival

A consortium of five organizations with 450 hospitals has set up a not-for-profit generic drug company to bring down prices.

Paul Singer Photo: Reuters: Steve Marcus Elliott Associates seeks allies in battle for Bezeq

The fund is trying to join forces with other Bezeq shareholders to replace company directors.

Shekels Photo: Shutterstock HSBC sees shekel weakening

The bank predicts that the shekel-dollar exchange rate will rise to NIS 3.51/$.

Mor Assia and Shelly Hod Moyal  photo: Ronen Fadida The Israeli women VCs taking on blockchain

Mor Assia and Shelly Hod Moyal say theirs is the venture capital fund of the future  - and a 300% return is hard to argue with.

Shekels Photo: Shutterstock Shekel resumes gains

The Israeli currency is moving strongly back towards the key NIS 3.40/$ threshold.

Akeneo and Sigmento teams  photo: PR  - courtesy Rosebud Communications Akeneo buys Israeli product data automation co Sigmento

Sigmento founders Izzy Cohen, Yoav Maor and Yonatan Maor will join the management team of French company Akeneo.

Bezhalel Machlis  photo: Tamar Matsafi Elbit Systems wins $85m contract in Europe

The contract is for advanced ground-based electronic warfare and signal intelligence systems.

Gershon Salkind Photo: PR Gershon Salkind's Elco shares to be divided equally between sons

Daniel and Michael Salkind will inherit their father's stake in the company.

Eyal Waldman  photo: Tamar Matzafi Starboard escalates Mellanox fight

US activist fund Starboard is demanding the replacement of Mellanox's board of directors.

Ohad Haber Photo: PR Irrigation co IRRI-Altal set for Toronto offering

The Kibbutz Ramat David-based company plans to merge with a stock exchange shell in order to raise C$5-10 million.

Ori Yehudai  photo: Eyal Izhar Frutarom sells krill oil business for $26.4m

Norway's Aker BioMarine will buy the business bought by Frutarom from Enzymotec.

Shekels Photo: Shutterstock Bank of Israel interventions actually work

The test of success for the Bank of Israel's policy is the superb stability and macroeconomic state of the Israeli economy, argues Prof. Rafi Melnick.

Shekels Photo: Shutterstock BoI weakens shekel with foreign currency purchases

The shekel had been hovering around the NIS 3.40/$ level for the first time since July 2011.

Joseph Shapira Comptroller to deliver damning report on IMI privatization

The report is in the final stages of preparation for publication after a year's delay.

Eduardo Elsztain  photo: Tamar Matzafi Eduardo Elsztain mulls bid for Bezeq

To go ahead with an acquisition of Bezeq, Elsztain will have to give up his controlling interest in Cellcom.

Teddy Sagi  photo: Yossi Cohen UK Financial Conduct Authority awards license to SafeCharge

The UK license is in addition to the Israeli payments technology company's existing authorization as a European Electronic Money Institution.

Erez Antebi Allot buys Israeli home cybersecurity co Netonomy

Netonomy develops software-based cybersecurity for the connected home.

David Granot Photo: Tamar Matsafi Elliott Associates demands shake-up of Bezeq board

The fund, which holds a 4.8% stake in Bezeq, has written to company chairman David Granot saying the board in its current composition "is no longer fit for its purpose."

Israel Chemicals Photo: Eyal Yizhar Potash Corp. selling Israel Chemicals stake

Potash Corp. has agreed a sale of its 13.8% holding in Israel Chemicals to a group of buyers at a substantial discount on the market price.

Bezeq Bezeq raising NIS 1.2b debt

Bezeq has signed an agreement for a future placement of its series 9 bonds, and has secured a NIS 600 million bank loan.

Karnit Flug  photo: Rami Zarnegar "Bank of Israel can neutralize algo trading in shekel"

Market players say the central bank's intervention so far has not been serious, but that it has advantages it can exploit.

Teva Photo: Reuters FDA approves Teva leukemia treatment

Trisenox was approved as a first-line treatment for acute promyelocytic leukemia.

Chaim Hurvitz Teva corruption settlement doesn't cover co officers

The investigation into the responsibility of Teva managers for bribes paid by subsidiaries in Russia and Ukraine continues.

Roots Photo: PR Roots triples its value on Australian Securities Exchange

The Israeli agtech company has developed a unique environmentally friendly system for heating and cooling crop roots.

Itay Ben-Zeev Photo: Eyal Yitzhar TASE plans its own IPO for 2019

TASE CEO: The growth potential of the TASE is enormous.

Karnit Flug Algo traders boost shekel against dollar

The Bank of Israel has identified one of the reasons for the shekel's recent strengthening against the dollar to a 6.5-year peak.

Gil Shwed Photo: Reuters Oppenheimer backs Check Point and cybersecurity sector

Oppenheimer anslyst Shaul Eyal sees companies engaged in cybersecurity like Check Point and Cyberark enjoying even better returns in 2018.  

Mergers and acquisitions Photo: To Go Taldor buys software co Spectory for NIS 15m

Spectory has become a leading player in software development for open code in general and complex user interfaces in particular.

Karnit Flug  photo: Eyal Izhar BoI: Return on housing beat stocks over past decade

Over a thirty-year period, however, investment in stocks is ahead.

Teva Photo: Tamar Matsafi Teva agrees future of Abic Netanya with workers

Employees at the site will be offered voluntary retirement on enhanced terms.

IMI Magic Spear Photo: PR Reports of progress on IMI deal boost Elbit Systems

Elbit Systems' share price is sharply up on the Tel Aviv Stock Exchange this morning.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018